Zacks Investment ResearchTue, 28 Apr 2026 13:46:16 GMTWave Life Sciences (WVE) Reports Q1 Loss, Beats Revenue EstimatesWVE-0.83%
The Motley FoolWed, 01 Apr 2026 20:45:00 GMTIs This Weight Loss Drug Stock a Buy on the Dip?WVE-0.83%
Zacks Investment ResearchWed, 01 Apr 2026 08:21:05 GMTWave Life Sciences (WVE) Surges 9.5%: Is This an Indication of Further Gains?WVE-0.83%
Seeking AlphaFri, 27 Mar 2026 20:15:55 GMTWave Life Sciences Ltd. (WVE) Discusses Positive Interim Phase I Data from INLIGHT Trial of WVE-007 for Obesity TranscriptWVE-0.83%
Zacks Investment ResearchFri, 27 Mar 2026 16:25:14 GMTWVE Posts Interim Data From Phase I Study on WVE-007, Stock TanksWVE-0.83%
24/7 Wall StreetFri, 27 Mar 2026 14:00:35 GMTWave Life Sciences Slips as Obesity Data Fails to ConvinceWVE-0.83%
The Motley FoolThu, 26 Mar 2026 21:30:06 GMTStock Market Today, March 26: Wave Life Sciences Plunges After High Dose Obesity Drug Data DisappointsWVE-0.83%
BenzingaThu, 26 Mar 2026 15:25:09 GMTWhy Is Wave Life Sciences Stock Falling After Weight Loss Study Data?WVE-0.83%
Seeking AlphaThu, 26 Feb 2026 20:57:46 GMTWave Life Sciences Ltd. (WVE) Q4 2025 Earnings Call TranscriptWVE-0.83%
Zacks Investment ResearchThu, 26 Feb 2026 18:21:18 GMTWave Life Sciences (WVE) Reports Q4 Loss, Tops Revenue EstimatesWVE-0.83%
